Valuation: Mega Lifesciences

Market Cap 33.13B 987M 863M 796M 732M 1.39B 95B 1.41B 9.51B 3.73B 46.44B 3.71B 3.63B 160B P/E 2026 *
14.3x
P/E 2027 * 13.5x
Enterprise Value 28.52B 850M 743M 685M 630M 1.19B 81.78B 1.21B 8.18B 3.21B 39.97B 3.19B 3.12B 138B EV / Sales 2026 *
1.92x
EV / Sales 2027 * 1.82x
Free-Float
38.61%
Yield 2026 *
4.6%
Yield 2027 * 4.94%
1 day+0.66%
1 week+0.66%
Current month+3.40%
1 month+11.76%
3 months+10.95%
6 months+9.35%
Current year+13.43%
1 week 36.75
Extreme 36.75
38.5
1 month 34
Extreme 34
38.5
Current year 31.5
Extreme 31.5
40
1 year 26.75
Extreme 26.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 61 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Date Insider Type Main position Quantity % Market Cap.
28/04/25Buy

Chief Executive Officer

100,000 0.0115%
27/04/25Buy

Chief Executive Officer

150,000 0.0172%
27/04/25Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
+0.66%+0.66%+40.74%-1.94% 985M
-0.00%-4.95%+49.75%+158.46% 1,028B
-2.00%-6.00%+59.56%+55.65% 611B
+2.07%-3.32%+31.10%+81.23% 432B
+0.98%-1.40%+29.49%+23.12% 323B
-0.34%-3.10%+27.00%+43.66% 277B
+1.63%-11.76%+19.72%+23.20% 257B
+3.39%+2.29%-23.68%-38.33% 217B
+1.66%-2.75%+22.34%+57.07% 192B
+2.31%-3.22%+20.52%+69.64% 161B
Average +0.84%-4.58%+27.65%+47.18% 349.93B
Weighted average by Cap. +0.39%-5.51%+35.88%+77.56%

Financials

2026 *2027 *
Net sales 14.88B 443M 388M 358M 329M 623M 42.66B 633M 4.27B 1.67B 20.85B 1.66B 1.63B 71.87B 15.61B 465M 407M 375M 345M 654M 44.77B 665M 4.48B 1.76B 21.88B 1.75B 1.71B 75.42B
Net income 2.32B 69.14M 60.45M 55.76M 51.26M 97.12M 6.65B 98.78M 666M 261M 3.25B 260M 254M 11.21B 2.46B 73.31M 64.09M 59.13M 54.35M 103M 7.05B 105M 706M 277M 3.45B 275M 269M 11.88B
Net Debt -4.61B -137M -120M -111M -102M -193M -13.22B -196M -1.32B -519M -6.46B -516M -505M -22.28B -4.76B -142M -124M -114M -105M -199M -13.64B -203M -1.36B -536M -6.67B -532M -521M -22.98B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
14/07/26 THB 38.00 +0.66% 873,912
14/07/26 THB 37.75 +1.34% 737,163
13/07/26 THB 37.25 +0.68% 700,210
10/07/26 THB 37.00 -1.33% 702,563
09/07/26 THB 37.50 +1.35% 457,501
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
38.00THB
Average target price
41.14THB
Spread / Average Target
+8.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock